1. Home
  2. KTTA vs FENG Comparison

KTTA vs FENG Comparison

Compare KTTA & FENG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$0.44

Market Cap

18.1M

Sector

Health Care

ML Signal

HOLD

Logo Phoenix New Media Limited

FENG

Phoenix New Media Limited

SELL

Current Price

$1.40

Market Cap

18.1M

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
KTTA
FENG
Founded
2020
1998
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
18.1M
18.1M
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
KTTA
FENG
Price
$0.44
$1.40
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 141.8K
2.0K
Earning Date
11-12-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 77.07
N/A
EPS
N/A
★ N/A
Revenue
★ $486,559.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 3130.37
N/A
52 Week Low
$0.28
$1.39
52 Week High
$2.06
$2.66

Technical Indicators

Market Signals
Indicator
KTTA
FENG
Relative Strength Index (RSI) 35.47 39.97
Support Level $0.43 N/A
Resistance Level $0.52 $1.52
Average True Range (ATR) 0.03 0.02
MACD -0.01 -0.00
Stochastic Oscillator 9.01 0.00

Price Performance

Historical Comparison
KTTA
FENG

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

About FENG Phoenix New Media Limited

Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives all of its revenue from PRC.

Share on Social Networks: